ReviewClinical interventions in aging2018

Genome-editing applications of CRISPR-Cas9 to promote in vitro studies of Alzheimer's disease.

Vo Van Giau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.